COVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus

  • STATUS
    Recruiting
  • participants needed
    300
  • sponsor
    Hospices Civils de Lyon
Send
Updated on 16 February 2024
See if I qualify
strain
fever
coronavirus
cough
influenza
covid-19
SARS
nosocomial infection
respiratory infection
acute respiratory syndrome (sars)
pharyngeal pain

Summary

Infection with the SARS-CoV-2 coronavirus strain is associated with severe morbidity and mortality estimated today from 2% to 4%. Elderly patients or patients with serious chronic conditions justifying hospitalization are particularly at risk. The risk of infection with SARS-CoV-2 during hospitalization is also substantial and increased in fragile patients. Several cases of infection among Healthcare Professionals had been reported.

The hypothesis is that similar to the corona virus agent responsible for SRAS and the influenza virus, nosocomial outbreaks of SARS-CoV-2 to be feared. Health care professionals and caregivers are populations-at-risk as they are exposed in the community and can transmit SARS-CoV-2 to hospitalized patients, and are also exposed to hospitalized patients infected with SARS-CoV-2.

Describing hospital-acquired cases and SARS-CoV-2 infection transmission chains in healthcare settings is vitally essential to achieve control of this epidemic. To improve the quality of care and patient safety, this data must be accompanied by an analysis of the impact of infection control measures. In addition, an effective infection control program is urgently required to control the spread of the virus and protect both uninfected patients who require care for other medical or surgical conditions as well as health care professionals.

The main objective of this prospective, non-interventional - observational, hospital based study in adults and children is to describe and document suspected or confirmed cases of nosocomial SARS-CoV-2 infection, the clinical spectrum and the determinants (risk factors/protective factors) at participating hospitals.

Characterization of the clinical features of the SARS-CoV-2 infection will help to identify potential sources of virus transmission as rapidly as possible and enable implementation of appropriate hygiene practices in hospitals.

Details
Condition Viral infection
Age 100years or below
Treatment nosocomial infection/hospital acquired infection
Clinical Study IdentifierNCT04290780
SponsorHospices Civils de Lyon
Last Modified on16 February 2024

Eligibility

 Yes No Not Sure

Inclusion Criteria

) Any adult or child or member of the nursing staff from the study
participant hospital who presents an infectious syndrome including the
following definition
) Suspect Case
Fever above 37.8 C if no antipyretics are taken; And or Cough or pharyngeal
pain or other symptom suggestive of respiratory infection. AND at least 1 of
the following
characteristics
return from a trip to China, or to a country in which the increase in the incidence of infections in SARS-CoV-2 has been proven
close contact (sharing the same place of family, professional life, same plane, etc.) with a person defined as a suspected or confirmed case
Occurring in an establishment having received at least one case of suspected or confirmed infection at SARS-CoV-2
Or 3) Confirmed Case: The same clinical definitions, in addition to a positive
RT-PCR-type virological diagnostic result specific to SARS-CoV-2

Exclusion Criteria

Anyone who does not meet the above definition
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

strain
fever
coronavirus
cough
influenza
covid-19
SARS
nosocomial infection
respiratory infection
acute respiratory syndrome (sars)
pharyngeal pain

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.